Can abnormal uterine bleeding be a presenting sign of systemic lupus erythematosus?

Can Abnormal Uterine Bleeding Be a Presenting Sign of SLE?

Yes, abnormal uterine bleeding can be a presenting manifestation of systemic lupus erythematosus, though it is uncommon. While the major guidelines on SLE management do not specifically list AUB as a typical presenting feature, case reports document rare instances where gynecological hemorrhagic complications served as the initial presentation of previously undiagnosed SLE.

Evidence for AUB as Initial SLE Presentation

The literature contains documented cases of hemorrhagic gynecological events as presenting symptoms:

• Ruptured hemorrhagic corpus luteum has been reported as the initial presentation of SLE with nephritis and positive lupus anticoagulant 1
• Infected ovarian hematoma presenting as an inflammatory pelvic mass was the first manifestation in a patient with SLE-induced coagulation defects 2

These cases suggest that coagulopathy associated with SLE (particularly lupus anticoagulant or thrombocytopenia) can cause intraovarian or corpus luteum hemorrhage that manifests as acute abnormal bleeding.

Menstrual Disturbances in Established SLE

Once SLE is diagnosed, menstrual abnormalities are actually quite common:

• 60% of SLE patients experience menstrual disturbances including amenorrhea (12.7%), oligomenorrhea (44.5%), and menorrhagia (10.9%) 3
• Disease activity is the major factor: patients with SLEDAI ≥8 have significantly higher rates of menstrual irregularities 4
• High-dose glucocorticoids (≥30 mg/day prednisone) and cyclophosphamide exposure contribute to menstrual dysfunction 3, 4

Clinical Approach When AUB Raises Suspicion for SLE

When evaluating a patient with AUB, consider SLE if accompanied by:

• Systemic symptoms: fever, fatigue, weight loss, arthralgias
• Hematologic abnormalities: unexplained thrombocytopenia, anemia, or prolonged aPTT
• Other organ involvement: rash (especially malar or photosensitive), nephritis, serositis
• Young age with severe hemorrhagic complications (ruptured corpus luteum, ovarian hematoma)

Diagnostic workup should include:

• Complete blood count with differential
• Coagulation studies (PT, aPTT, lupus anticoagulant)
• ANA, anti-dsDNA, complement levels (C3, C4)
• Urinalysis and renal function
• Transvaginal ultrasound to assess structural causes 5

Important Caveats

Do not assume AUB is due to SLE without excluding structural causes first. The ACR Appropriateness Criteria emphasize that structural causes (polyps, leiomyomas, adenomyosis, malignancy) are the primary differential for AUB and require imaging evaluation 5.

The mechanism linking SLE to AUB is primarily through:

1. Antiphospholipid antibodies causing hemorrhagic complications
2. Thrombocytopenia from immune destruction
3. Disease activity affecting ovarian function and hormonal regulation
4. Medication effects (particularly cyclophosphamide and high-dose steroids)

While EULAR guidelines extensively address reproductive health in established SLE patients 6, they do not identify AUB as a typical presenting feature, reinforcing that this is an uncommon but documented presentation requiring high clinical suspicion when accompanied by other suggestive features.